• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to (R)-Methyl 3-aminobutanoate (CAS No. 103189-63-5)

(R)-Methyl 3-aminobutanoate, with the chemical formula C₆H₁₃NO₂, is a significant compound in the field of chemo-biopharmaceuticals. This enantiomerically pure compound is widely recognized for its role in synthetic chemistry and pharmacological applications. Its CAS number, 103189-63-5, uniquely identifies it in scientific literature and industrial processes, underscoring its importance in both research and development.

The compound belongs to the class of α-amino esters, which are known for their versatility in medicinal chemistry. Specifically, (R)-Methyl 3-aminobutanoate is an optically active form, meaning it exists as a single enantiomer with a specific three-dimensional arrangement of atoms. This chirality is crucial in pharmaceuticals, as the biological activity of many drugs is highly dependent on their stereochemical configuration.

In recent years, there has been a surge in research focusing on the applications of chiral auxiliaries and ligands in asymmetric synthesis. (R)-Methyl 3-aminobutanoate has emerged as a valuable building block in this context. Its structural features make it an excellent candidate for constructing complex molecules with high enantiomeric purity. This has particular relevance in the development of novel therapeutic agents where specificity and efficacy are paramount.

One of the most compelling aspects of (R)-Methyl 3-aminobutanoate is its utility in peptide mimetics and peptidomimetic drug design. Peptides are essential biomolecules that play a myriad of roles in biological processes, but their use as drugs is often limited by issues such as poor bioavailability and rapid degradation. Peptidomimetics, which are synthetic analogs of peptides, offer a solution to these challenges by mimicking the biological activity of peptides while possessing improved pharmacokinetic properties.

Current research indicates that (R)-Methyl 3-aminobutanoate can be incorporated into peptidomimetic structures to enhance their stability and bioactivity. For instance, studies have demonstrated its effectiveness in creating cyclic peptidomimetics that exhibit potent inhibitory effects on various enzymatic targets. These findings highlight the compound's potential as a key intermediate in the synthesis of next-generation therapeutics.

Furthermore, (R)-Methyl 3-aminobutanoate has found applications in the field of enzyme inhibition. Many diseases are caused by the overactivity or underactivity of specific enzymes, making enzyme inhibition a promising strategy for drug development. The compound's ability to act as a substrate or inhibitor analog has been explored in several studies. For example, it has been shown to modulate the activity of acetylcholinesterase, an enzyme implicated in Alzheimer's disease.

The growing interest in (R)-Methyl 3-aminobutanoate is also driven by its role in synthetic methodologies that promote sustainable chemistry. Green chemistry principles emphasize the development of processes that minimize environmental impact while maintaining high efficiency and yield. The use of readily available starting materials like (R)-Methyl 3-aminobutanoate aligns with these principles, as it allows for scalable and environmentally friendly syntheses.

In addition to its pharmaceutical applications, (R)-Methyl 3-aminobutanoate has shown promise in agrochemical research. The development of novel pesticides and herbicides often requires complex molecular architectures that can interact selectively with biological targets. The compound's structural versatility makes it a valuable tool for designing such agrochemicals.

Recent advancements in computational chemistry have further enhanced the utility of (R)-Methyl 3-aminobutanoate. Molecular modeling studies have revealed insights into its interactions with biological targets at an atomic level, aiding in the rational design of more effective derivatives. These computational approaches complement traditional experimental methods, providing a more comprehensive understanding of the compound's behavior.

The synthesis of (R)-Methyl 3-aminobutanoate itself is another area where innovation continues to thrive. Modern synthetic techniques have enabled more efficient and cost-effective production methods, making it more accessible for industrial applications. Catalytic processes, particularly those involving biocatalysts or transition metal complexes, have been explored to improve yield and reduce waste.

Looking ahead, the future prospects for (R)-Methyl 3-aminobutanoate appear bright. As our understanding of molecular interactions deepens and new synthetic tools become available, its applications are likely to expand further. Whether in drug discovery, materials science, or agrochemistry, this compound continues to play a pivotal role in advancing scientific knowledge and technological innovation.

• 77856-53-2((3S)-3-amino-5-methoxy-5-oxopentanoic acid)
• 115880-49-4(ethyl (3R)-3-aminobutanoate)
• 6078-06-4(Methyl 3-aminobutanoate)
• 88598-13-4(Pentanedioic acid, 3-amino-, monomethyl ester)
• 83509-89-1((S)-3-Amino-butyric acid methyl ester)
• 77313-09-8(Dimethyl 3-aminopentanedioate)
• 532435-35-1(methyl (3R)-3-aminopentanoate hydrochloride)
• 22657-48-3(Butanoic acid,3-amino-, ethyl ester, (3S)-)
• 5303-65-1(Ethyl 3-aminobutanoate)
• 833453-79-5(Octanoic acid, 3-amino-, methyl ester, (3S)-)